Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SURG vs GSAT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SURG
SurgePays, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$11M
5Y Perf.-96.4%
GSAT
Globalstar, Inc.

Telecommunications Services

Communication ServicesNASDAQ • US
Market Cap$10.33B
5Y Perf.+1726.9%

SURG vs GSAT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SURG logoSURG
GSAT logoGSAT
IndustrySoftware - ApplicationTelecommunications Services
Market Cap$11M$10.33B
Revenue (TTM)$50M$262M
Net Income (TTM)$-42M$-50M
Gross Margin-38.6%57.2%
Operating Margin-78.8%1.4%
Total Debt$5M$542M
Cash & Equiv.$12M$391M

SURG vs GSATLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SURG
GSAT
StockMay 20May 26Return
SurgePays, Inc. (SURG)1003.6-96.4%
Globalstar, Inc. (GSAT)1001826.9+1726.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: SURG vs GSAT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GSAT leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. SurgePays, Inc. is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SURG
SurgePays, Inc.
The Income Pick

SURG is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • beta 1.30
  • Lower volatility, beta 1.30, Low D/E 30.1%, current ratio 2.95x
  • Beta 1.30, current ratio 2.95x
Best for: income & stability and sleep-well-at-night
GSAT
Globalstar, Inc.
The Growth Play

GSAT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 11.9%, EPS growth -195.0%, 3Y rev CAGR 26.3%
  • 201.8% 10Y total return vs SURG's -99.1%
  • 11.9% revenue growth vs SURG's -55.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthGSAT logoGSAT11.9% revenue growth vs SURG's -55.6%
Quality / MarginsGSAT logoGSAT-19.0% margin vs SURG's -83.4%
Stability / SafetySURG logoSURGBeta 1.30 vs GSAT's 2.08, lower leverage
DividendsGSAT logoGSAT0.1% yield; 2-year raise streak; the other pay no meaningful dividend
Momentum (1Y)GSAT logoGSAT+305.2% vs SURG's -78.9%
Efficiency (ROA)GSAT logoGSAT-2.3% ROA vs SURG's -242.4%, ROIC -0.1% vs -229.7%

SURG vs GSAT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SURGSurgePays, Inc.
FY 2023
Lead Generation
100.0%$7M
GSATGlobalstar, Inc.
FY 2024
Service
69.3%$238M
Services, SPOT
12.0%$41M
Commercial loT
7.7%$26M
Services, Duplex
5.9%$20M
Product
3.7%$13M
Services, Other
1.4%$5M

SURG vs GSAT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGSATLAGGINGSURG

Income & Cash Flow (Last 12 Months)

GSAT leads this category, winning 4 of 6 comparable metrics.

GSAT is the larger business by revenue, generating $262M annually — 5.2x SURG's $50M. GSAT is the more profitable business, keeping -19.0% of every revenue dollar as net income compared to SURG's -83.4%.

MetricSURG logoSURGSurgePays, Inc.GSAT logoGSATGlobalstar, Inc.
RevenueTrailing 12 months$50M$262M
EBITDAEarnings before interest/tax-$39M$93M
Net IncomeAfter-tax profit-$42M-$50M
Free Cash FlowCash after capex-$26M$151M
Gross MarginGross profit ÷ Revenue-38.6%+57.2%
Operating MarginEBIT ÷ Revenue-78.8%+1.4%
Net MarginNet income ÷ Revenue-83.4%-19.0%
FCF MarginFCF ÷ Revenue-50.9%+57.6%
Rev. Growth (YoY)Latest quarter vs prior year+2.9%+2.1%
EPS Growth (YoY)Latest quarter vs prior year+47.2%-121.9%
GSAT leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

SURG leads this category, winning 2 of 3 comparable metrics.
MetricSURG logoSURGSurgePays, Inc.GSAT logoGSATGlobalstar, Inc.
Market CapShares × price$11M$10.3B
Enterprise ValueMkt cap + debt − cash$4M$10.5B
Trailing P/EPrice ÷ TTM EPS-0.23x-138.10x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple119.09x
Price / SalesMarket cap ÷ Revenue0.18x41.28x
Price / BookPrice ÷ Book value/share0.70x28.58x
Price / FCFMarket cap ÷ FCF57.85x
SURG leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

GSAT leads this category, winning 6 of 9 comparable metrics.

GSAT delivers a -13.7% return on equity — every $100 of shareholder capital generates $-14 in annual profit, vs $-10 for SURG. SURG carries lower financial leverage with a 0.30x debt-to-equity ratio, signaling a more conservative balance sheet compared to GSAT's 1.51x. On the Piotroski fundamental quality scale (0–9), GSAT scores 5/9 vs SURG's 2/9, reflecting solid financial health.

MetricSURG logoSURGSurgePays, Inc.GSAT logoGSATGlobalstar, Inc.
ROE (TTM)Return on equity-10.1%-13.7%
ROA (TTM)Return on assets-2.4%-2.3%
ROICReturn on invested capital-2.3%-0.1%
ROCEReturn on capital employed-177.3%-0.1%
Piotroski ScoreFundamental quality 0–925
Debt / EquityFinancial leverage0.30x1.51x
Net DebtTotal debt minus cash-$7M$151M
Cash & Equiv.Liquid assets$12M$391M
Total DebtShort + long-term debt$5M$542M
Interest CoverageEBIT ÷ Interest expense-40.65x-0.07x
GSAT leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GSAT leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in GSAT five years ago would be worth $49,382 today (with dividends reinvested), compared to $715 for SURG. Over the past 12 months, GSAT leads with a +305.2% total return vs SURG's -78.9%. The 3-year compound annual growth rate (CAGR) favors GSAT at 80.1% vs SURG's -49.3% — a key indicator of consistent wealth creation.

MetricSURG logoSURGSurgePays, Inc.GSAT logoGSATGlobalstar, Inc.
YTD ReturnYear-to-date-67.4%+27.3%
1-Year ReturnPast 12 months-78.9%+305.2%
3-Year ReturnCumulative with dividends-86.9%+484.1%
5-Year ReturnCumulative with dividends-92.8%+393.8%
10-Year ReturnCumulative with dividends-99.1%+201.8%
CAGR (3Y)Annualised 3-year return-49.3%+80.1%
GSAT leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SURG and GSAT each lead in 1 of 2 comparable metrics.

SURG is the less volatile stock with a 1.30 beta — it tends to amplify market swings less than GSAT's 2.08 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GSAT currently trades 98.3% from its 52-week high vs SURG's 16.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSURG logoSURGSurgePays, Inc.GSAT logoGSATGlobalstar, Inc.
Beta (5Y)Sensitivity to S&P 5001.30x2.08x
52-Week HighHighest price in past year$3.45$82.85
52-Week LowLowest price in past year$0.46$17.24
% of 52W HighCurrent price vs 52-week peak+16.2%+98.3%
RSI (14)Momentum oscillator 0–10039.966.4
Avg Volume (50D)Average daily shares traded378K1.5M
Evenly matched — SURG and GSAT each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

GSAT is the only dividend payer here at 0.10% yield — a key consideration for income-focused portfolios.

MetricSURG logoSURGSurgePays, Inc.GSAT logoGSATGlobalstar, Inc.
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$66.00
# AnalystsCovering analysts5
Dividend YieldAnnual dividend ÷ price+0.1%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$0.08
Buyback YieldShare repurchases ÷ mkt cap+5.6%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

GSAT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SURG leads in 1 (Valuation Metrics). 1 tied.

Best OverallGlobalstar, Inc. (GSAT)Leads 3 of 6 categories
Loading custom metrics...

SURG vs GSAT: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is SURG or GSAT a better buy right now?

For growth investors, Globalstar, Inc.

(GSAT) is the stronger pick with 11. 9% revenue growth year-over-year, versus -55. 6% for SurgePays, Inc. (SURG). Analysts rate Globalstar, Inc. (GSAT) a "Hold" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SURG or GSAT?

Over the past 5 years, Globalstar, Inc.

(GSAT) delivered a total return of +393. 8%, compared to -92. 8% for SurgePays, Inc. (SURG). Over 10 years, the gap is even starker: GSAT returned +201. 8% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SURG or GSAT?

By beta (market sensitivity over 5 years), SurgePays, Inc.

(SURG) is the lower-risk stock at 1. 30β versus Globalstar, Inc. 's 2. 08β — meaning GSAT is approximately 60% more volatile than SURG relative to the S&P 500. On balance sheet safety, SurgePays, Inc. (SURG) carries a lower debt/equity ratio of 30% versus 151% for Globalstar, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — SURG or GSAT?

By revenue growth (latest reported year), Globalstar, Inc.

(GSAT) is pulling ahead at 11. 9% versus -55. 6% for SurgePays, Inc. (SURG). On earnings-per-share growth, the picture is similar: Globalstar, Inc. grew EPS -195. 0% year-over-year, compared to -273. 2% for SurgePays, Inc.. Over a 3-year CAGR, GSAT leads at 26. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SURG or GSAT?

Globalstar, Inc.

(GSAT) is the more profitable company, earning -25. 2% net margin versus -75. 1% for SurgePays, Inc. — meaning it keeps -25. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GSAT leads at -0. 4% versus -68. 6% for SURG. At the gross margin level — before operating expenses — GSAT leads at 66. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SURG or GSAT?

In this comparison, GSAT (0.

1% yield) pays a dividend. SURG does not pay a meaningful dividend and should not be held primarily for income.

07

Is SURG or GSAT better for a retirement portfolio?

For long-horizon retirement investors, SurgePays, Inc.

(SURG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Globalstar, Inc. (GSAT) carries a higher beta of 2. 08 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SURG: -99. 1%, GSAT: +201. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SURG and GSAT?

These companies operate in different sectors (SURG (Technology) and GSAT (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SURG

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 145%
Run This Screen
Stocks Like

GSAT

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 34%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SURG and GSAT on the metrics below

Revenue Growth>
%
(SURG: 291.6% · GSAT: 2.1%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.